Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735) [Phase 4]

View source ↗

Summary

A Phase 4 double-dummy trial compared desloratadine 5 mg daily, cetirizine 10 mg daily, and placebo in adults with chronic idiopathic urticaria; the study is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine (cetirizine)
  • Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Urticaria | Phase 4 | Status: COMPLETED